Targeting health-related quality of life in patients with myelodysplastic syndromes – Current knowledge and lessons to be learned-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting health-related quality of life in patients with myelodysplastic syndromes – Current knowledge and lessons to be learned

Published:2021-11 Issue: Volume:50 Page:100851
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Oliva Esther N.,Platzbecker Uwe,Fenaux Pierre,Garcia-Manero Guillermo,LeBlanc Thomas W.,Patel Bhumika J.,Kubasch Anne Sophie,Sekeres Mikkael A.

Funder

AbbVie

American Cancer Society

National Institute of Nursing Research

National Institutes of Health

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference110 articles.

1. Myelodysplastic syndromes: updates and nuances;Dao;Med Clin North Am,2017

2. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012;Bonadies;Cancer Epidemiol,2017

3. Why are myelodysplastic syndromes unrecognized and underdiagnosed? A primary care perspective;Khan;Am J Med,2012

4. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries;Cogle;Blood,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life considerations in myelodysplastic syndrome: not only fatigue;Expert Review of Hematology;2024-07-12

2. Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS);HemaSphere;2024-05

3. Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms;Cancers;2024-04-19

4. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE;Transfusion;2024-02

5. Are We Ready For “Triplet” Therapy in Higher-Risk MDS?;Clinical Hematology International;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3